AIDS-related Diffuse Mixed Cell Lymphoma

7 clinical trials · Condition

Record	Firm	Date
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma (NCT01775475)	AIDS Malignancy Consortium	2016-09-15
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma (NCT01769911)	Fred Hutchinson Cancer Center	2015-02-01
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274)	National Cancer Institute (NCI)	2010-06-01
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747)	National Cancer Institute (NCI)	2009-08-01
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma (NCT00022555)	National Cancer Institute (NCI)	2001-11-01
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (NCT00005811)	National Cancer Institute (NCI)	2000-04-01
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593)	Fred Hutchinson Cancer Center	1999-11-01

Every clearance here is in the API, with alerts when new ones post.